-
Mashup Score: 15What Will the New Cardiovascular Risk Calculator Mean for Patients? - 3 month(s) ago
Analysis forecasts more heart attacks and strokes as fewer people become eligible for meds
Source: hms.harvard.eduCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial - 4 month(s) ago
In PWH, CD4 nadir associates with clonal hematopoiesis, a risk factor of atherosclerosis and cancer.Clonal hematopoiesis is less common outside of North Am
Source: ashpublications.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 5Body Composition in Anti-Obesity Medication Trials - 7 month(s) ago
This Viewpoint contends that focusing only on weight loss as the primary weight medication end point is an inaccurate measure of medication efficacy for both patients and clinicians.
Source: jamanetwork.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 21Medicare to cover obesity drugs, but not for weight loss - 8 month(s) ago
The Centers for Medicare and Medicaid Services (CMS) issued guidance allowing for the coverage of anti-obesity medications, but only in cases they are indicated for treating conditions other than o…
Source: thehill.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0News Details - 8 month(s) ago
Bagsværd, Denmark, 8 March 2024 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a label expansion for Wegovy ® based on a supplemental New Drug Application (sNDA) for the indication of reducing ri sks of major adverse cardiovascular events (MACE) including cardiovascular death, non-fatal heart attack (myocardial infarction) or non-fatal stroke in adults with either overweight or obesity and established cardiovascular disease (CVD). The approval is based on the
Source: www.novonordisk.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3Prediction of atrial fibrillation from at-home single-lead ECG signals without arrhythmias - 8 month(s) ago
npj Digital Medicine – Prediction of atrial fibrillation from at-home single-lead ECG signals without arrhythmias
Source: www.nature.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3Prediction of atrial fibrillation from at-home single-lead ECG signals without arrhythmias - 8 month(s) ago
npj Digital Medicine – Prediction of atrial fibrillation from at-home single-lead ECG signals without arrhythmias
Source: www.nature.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal - PubMed - 11 month(s) ago
The normal low-density lipoprotein (LDL) cholesterol range is 50 to 70 mg/dl for native hunter-gatherers, healthy human neonates, free-living primates, and other wild mammals (all of whom do not develop atherosclerosis). Randomized trial data suggest atherosclerosis progression and coronary heart di …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 161Paper page - SLiMe: Segment Like Me - 1 year(s) ago
Join the discussion on this paper page
Source: huggingface.coCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1To Worry or to Believe - 1 year(s) ago
In this narrative medicine essay, a current associate program director who entered medicine-pediatrics residency the year work-hours were capped and heard worried remarks about the quality of training residents would receive now hears the same worries expressed after residents voted to unionize at…
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet
Interesting analysis from @JamesDiao @rkwadhera @arjunmanrai @venkmurthy @kardiologykazi and others https://t.co/2ZysrAdXDs https://t.co/AP342MOmAZ Does the PREVENT equation lower calculated risk below treatment thresholds too much? Thoughts? #cvPrev @mchonig @pnatarajanmd